Background Population-based estimates of prevalence, risk distribution, and intervention
uptake inform delivery of control programmes for sexually transmitted infections (STIs). We …

In large metropolitan areas, which typically have the highest rates of gonorrhea, the
identification of chains of transmission by use of partner notification is problematic, and there …

Gonorrhoea and chancroid remain important infectious diseases worldwide, although the
global distribution of these diseases differs between the industrialised and developing …

High-level azithromycin resistance (AZM-HR), defined as a MIC of≥ 256 mg/liter, emerged
in Neisseria gonorrhoeae in the United Kingdom in 2004. To determine the mechanism of …

Background Gonorrhoea has been among the easiest infections to cure with antibiotics.
Nevertheless, emerging resistance has driven repeated treatment shifts. Decreased …

Background: There are currently no large general population epidemiological studies of
Mycoplasma genitalium (MG), which include prevalence, risk factors, symptoms and co …

Background Effective treatment of gonorrhoea is fundamental to public health control;
however, the ability of Neisseria gonorrhoeae to successively develop resistance to different …

The use of whole-genome sequencing as a tool for the study of infectious bacteria is of
growing clinical interest. Chlamydia trachomatis is responsible for sexually transmitted …

Antimicrobial resistance (AMR) in Neisseria gonorrhoeae has emerged for essentially all
antimicrobials following their introduction into clinical practice. During the latest decade …

The delivery of effective antimicrobial therapy is essential for public health control of
gonorrhoea, in the absence of a suitable vaccine. The antimicrobial agent chosen should …